Overexpression of CIP2A promotes bladder cancer progression by regulating EMT
Clin. transl. oncol. (Print)
; 18(3): 289-295, mar. 2016. ilus, graf
Artigo
em Inglês
| IBECS
| ID: ibc-148713
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
Background:
Bladder cancer is the second most common urological malignancy worldwide. CIP2A is a newly identified inhibitor of PP2A. Recent studies have highlighted a potential role for CIP2A in promoting the proliferation of several cancer cells. However, the role of CIP2A in bladder cancer still remains unclear.Methods:
The expression of CIP2A was detected by quantitative real-time polymerase chain reaction and IHC in bladder cancer tissues and bladder cancer cell lines. In addition, silencing of CIP2A with siRNA was performed in T24 cells, and the impact on proliferation, and apoptosis of T24 cells was analyzed.Results:
Our results found that CIP2A expression levels were higher in bladder cancer tissues and cell lines. Furthermore, CIP2A siRNA significantly reduced the proliferation rate of T24 cells, induced a significant population of early and late apoptosis, and could reverse EMT in T24 cells, indicates that CIP2A expression is increased in bladder cancer and implies a role of the protein in bladder cancer progression.Conclusions:
These results suggest that CIP2A is involved in tumor progression, and thus CIP2A could represent selective targets for the targeted treatments of bladder cáncer (AU)RESUMEN
No disponible
Buscar no Google
Coleções:
Bases de dados nacionais
/
Espanha
Contexto em Saúde:
ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis
Problema de saúde:
Neoplasia da Bexiga
Base de dados:
IBECS
Assunto principal:
Terapêutica
/
Urologia
/
Neoplasias da Bexiga Urinária
/
Biomarcadores
/
China
/
Apoptose
/
Tumor Misto Maligno
/
Fidelidade a Diretrizes
Limite:
Feminino
/
Humanos
/
Masculino
País/Região como assunto:
Ásia
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2016
Tipo de documento:
Artigo
Instituição/País de afiliação:
Southern Medical University/China